Advertisement

Tumor-Related Epilepsy Not Strong Prognostic Factor in Diffuse Glioma

0

Presence of tumor-related epilepsy not a significant predictor of survival in multivariate analyses

FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer

0

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy

Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy

0

Patient-reported outcomes appear to be similar to postoperative conventionally fractionated radiotherapy

In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity

0

Increased risk for death and relapse seen for children with overweight, obesity at two or more time points

NIH Scientists Still Face Layoffs Despite RFK Jr.’s Reassurances

0
By I. Edwards HealthDay Reporter TUESDAY, May 20, 2025 (HealthDay News) — Some of the nation's top brain researchers are still facing layoffs, even after...

MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer

0

Absence of progression correctly identified by subsequent MRI in nearly 95, 90, 70 percent of men with grade group 0, 1, 2, respectively

Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals

0

No cases of endometrial, ovarian, vaginal, or vulvar cancer were seen

Some Triple Negative Breast Cancers Might Be Avoided by Longer Breastfeeding

0

Authors say policy changes that support breastfeeding and address structural barriers are needed

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

0

Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery

NIH Research Cuts Leave Cancer Patient Facing Hard Choice

0
By I. Edwards HealthDay Reporter THURSDAY, May 15, 2025 (HealthDay News) — A mother with stage 4 colon cancer faces an uncertain future after federal...